The 340B Drug Pricing Program, established by Congress in 1992, was intended to provide discounted medications to hospitals that care for low-income and uninsured patients. However, what was conceived as a noble initiative to improve access to affordable medicines has been increasingly marred by allegations of abuse and exploitation by some participating hospitals.